yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36815262-9E05A7DD-4515-4384-9F7D-90CB131514A1
Q36815262-9E05A7DD-4515-4384-9F7D-90CB131514A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36815262-9E05A7DD-4515-4384-9F7D-90CB131514A1
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells.
P2860
Q36815262-9E05A7DD-4515-4384-9F7D-90CB131514A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36815262-9E05A7DD-4515-4384-9F7D-90CB131514A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
50359e93d74950d874373f7dbf75414f69213f1c
P2860
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.